Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonia M S Müller

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Blood|December 22, 2022
Chronic GVHD on the moveAntonia M S Müller
Praxis|May 2, 2019
[Chemotherapy-Free Treatment of Hematological Neoplasias: Dream or Reality?]Alexander Ring, Antonia M S Müller
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
5-Azacytidine/5-AzacitidineAntonia M S Müller, Mareike Florek
Haematologica|February 2, 2019
The stepchild in myeloma treatments: is allogeneic transplantation not so bad after all?Antonia M S Müller, Shaji K Kumar, Benedetto Bruno
European Heart Journal. Case Reports|October 18, 2021
Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case reportDidar Utebay, Harald Seeger, Antonia M S Müller, et al.
Annals of Hematology|October 14, 2004
Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiologyAntonia M S Müller, Gabriele Ihorst, Roland Mertelsmann, et al.
Cancer Biology & Therapy|February 3, 2009
Dramatic and durable efficacy of imatinib in an advanced angiosarcoma without detectable KIT and PDGFRA mutationsHolger Kiesel, Antonia M S Müller, Annette Schmitt-Graeff, et al.
Biotechnology Advances|February 12, 2022
Better by design: What to expect from novel CAR-engineered cell therapies?Vera Luginbuehl, Eytan Abraham, Karin Kovar, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinibSilke C Hofmann, Kristin Technau, Antonia M S Müller, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantationAntonia M S Müller, Jessica A Linderman, Mareike Florek, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Blood|December 22, 2022
Chronic GVHD on the moveAntonia M S Müller
Praxis|May 2, 2019
[Chemotherapy-Free Treatment of Hematological Neoplasias: Dream or Reality?]Alexander Ring, Antonia M S Müller
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
5-Azacytidine/5-AzacitidineAntonia M S Müller, Mareike Florek
Haematologica|February 2, 2019
The stepchild in myeloma treatments: is allogeneic transplantation not so bad after all?Antonia M S Müller, Shaji K Kumar, Benedetto Bruno
European Heart Journal. Case Reports|October 18, 2021
Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case reportDidar Utebay, Harald Seeger, Antonia M S Müller, et al.
Annals of Hematology|October 14, 2004
Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiologyAntonia M S Müller, Gabriele Ihorst, Roland Mertelsmann, et al.
Cancer Biology & Therapy|February 3, 2009
Dramatic and durable efficacy of imatinib in an advanced angiosarcoma without detectable KIT and PDGFRA mutationsHolger Kiesel, Antonia M S Müller, Annette Schmitt-Graeff, et al.
Biotechnology Advances|February 12, 2022
Better by design: What to expect from novel CAR-engineered cell therapies?Vera Luginbuehl, Eytan Abraham, Karin Kovar, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinibSilke C Hofmann, Kristin Technau, Antonia M S Müller, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantationAntonia M S Müller, Jessica A Linderman, Mareike Florek, et al.
Pageof 5